3,632
edits
No edit summary |
No edit summary |
||
Line 11: | Line 11: | ||
[https://pubmed.ncbi.nlm.nih.gov/31584918/ Retrospective Analysis of the Safety and Efficacy of Sugammadex Versus Neostigmine for the Reversal of Neuromuscular Blockade in Children] | [https://pubmed.ncbi.nlm.nih.gov/31584918/ Retrospective Analysis of the Safety and Efficacy of Sugammadex Versus Neostigmine for the Reversal of Neuromuscular Blockade in Children] | ||
[https://pubmed.ncbi.nlm.nih.gov/10983014/ Neuromuscular blockade in children] | [https://pubmed.ncbi.nlm.nih.gov/10983014/ Neuromuscular blockade in children] | ||
Line 17: | Line 18: | ||
[[TYK6 |Test Your Knowledge]]: unique advantage of rocuronium | [[TYK6 |Test Your Knowledge]]: unique advantage of rocuronium | ||
[https://pubmed.ncbi.nlm.nih.gov/21474022/ Assessment of neuromuscular blockade in children at the time of block reversal and the removal of the endotracheal tube] | [https://pubmed.ncbi.nlm.nih.gov/21474022/ Assessment of neuromuscular blockade in children at the time of block reversal and the removal of the endotracheal tube] |